ABOUT US

 

The Knowledge Network on Innovation and Access to Medicines is a project of the Global Health Centre at the Graduate Institute, Geneva. The project seeks to maximize the contributions of research and analysis to producing public health needs-driven innovation and globally-equitable access to medicines.

Data Sources:

TRIPS Flexibilities

Contribute to improve and update this page!

Provides an overview of the different compulsory licensing regimes in the 38 countries members of the European Patent Convention. For each country, the document provides the legal basis, grounds for applying a compulsory license, the general procedure, and statistics and jurisprudence.

KEI provides information regarding compulsory licensing, such as global norms and countries experiences, including the use of compulsory licensing in the United States, and compulsory licensing of medical patents in Europe, Latin America, Asia Pacific and Africa.

Updated monthly, the Parallel Distribution register give information on parallel distribution notices, which have been checked by the European Medicines Agency. The register promotes transparency about parallel distribution notices, and increases information which is available for national authorities, holders of marketing authorisation, parallel distributors, and wholesalers.

Database of international drug patent oppositions. Provides information including patent applications, patent office decisions, patent oppositions, and in which country(ies) related to selected drugs.

The database contains “instances when authorities have invoked, planned to invoke, or have been asked to invoke a TRIPS flexibility for public health reasons, in particular access to medicines.” In particular the database includes compulsory licensing, patent exceptions, parallel import, and the Least Developed Country transition provisions.​